Why is Akums Drugs falling/rising?

As of 11-Aug, Akums Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 479.55, reflecting a decrease of -3.1 (-0.64%). The stock has underperformed its sector by -1.55% today and has been on a downward trend for the last two days, with a total drop of -2.26%. Over the past week, the stock has fallen by -5.24%, and it has generated a significant loss of -40.33% over the past year. Despite a recent intraday high of Rs 514.85, the stock is trading below all its moving averages, indicating a bearish trend. Additionally, there has been a notable decline in investor participation, with delivery volume dropping by -58.07% compared to the five-day average. While the company has a low debt-to-equity ratio and an attractive valuation with a price-to-book value of 2.5, these factors are overshadowed by poor long-term growth prospects, as evidenced by a modest annual net sales growth of 6.10% and a significant drop in PAT by -21.6% in the latest quarter.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark Sensex, which has gained +3.15% year-to-date. The stock's -24.85% decline year-to-date and -40.33% drop over the past year highlight its underperformance relative to the market. This underperformance is further emphasized by the stock's negative returns over various periods, including -13.84% in the last month and -5.24% in the past week, compared to the Sensex's relatively stable performance. Overall, the combination of declining investor interest, poor quarterly results, and lackluster growth prospects contributes to the stock's downward trajectory.